TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) has provided an announcement.
Consun Pharmaceutical Group Ltd. has announced the scheduling of an Extraordinary General Meeting (EGM) on December 23, 2025, to discuss and approve the proposed adoption of a Share Award Scheme and amendments to its memorandum and articles of association. This move is aimed at holding treasury shares and adopting new governance documents, potentially impacting shareholder engagement and corporate governance practices.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$17.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company is involved in the development and distribution of pharmaceutical products, with a focus on enhancing its market presence through strategic initiatives.
Average Trading Volume: 3,173,245
Technical Sentiment Signal: Buy
Current Market Cap: HK$12.28B
See more data about 1681 stock on TipRanks’ Stock Analysis page.